Literature DB >> 19920356

MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice.

Rachel J Roth1, Annie M Le, Lei Zhang, Mario Kahn, Varman T Samuel, Gerald I Shulman, Anton M Bennett.   

Abstract

Oxidative myofibers, also known as slow-twitch myofibers, help maintain the metabolic health of mammals, and it has been proposed that decreased numbers correlate with increased risk of obesity. The transcriptional coactivator PPARgamma coactivator 1alpha (PGC-1alpha) plays a central role in maintaining levels of oxidative myofibers in skeletal muscle. Indeed, loss of PGC-1alpha expression has been linked to a reduction in the proportion of oxidative myofibers in the skeletal muscle of obese mice. MAPK phosphatase-1 (MKP-1) is encoded by mkp-1, a stress-responsive immediate-early gene that dephosphorylates MAPKs in the nucleus. Previously we showed that mice deficient in MKP-1 have enhanced energy expenditure and are resistant to diet-induced obesity. Here we show in mice that excess dietary fat induced MKP-1 overexpression in skeletal muscle, and that this resulted in reduced p38 MAPK-mediated phosphorylation of PGC-1alpha on sites that promoted its stability. Consistent with this, MKP-1-deficient mice expressed higher levels of PGC-1alpha in skeletal muscle than did wild-type mice and were refractory to the loss of oxidative myofibers when fed a high-fat diet. Collectively, these data demonstrate an essential role for MKP-1 as a regulator of the myofiber composition of skeletal muscle and suggest a potential role for MKP-1 in metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19920356      PMCID: PMC2786792          DOI: 10.1172/JCI39054

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  62 in total

1.  Skeletal muscle fiber-specific green autofluorescence: potential for stem cell engraftment artifacts.

Authors:  Kathyjo A Jackson; D Scott Snyder; Margaret A Goodell
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

2.  Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria.

Authors:  Carley R Benton; James G Nickerson; James Lally; Xiao-Xia Han; Graham P Holloway; Jan F C Glatz; Joost J F P Luiken; Terry E Graham; John J Heikkila; Arend Bonen
Journal:  J Biol Chem       Date:  2007-12-12       Impact factor: 5.157

3.  Skeletal muscle metabolism is a major determinant of resting energy expenditure.

Authors:  F Zurlo; K Larson; C Bogardus; E Ravussin
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 4.  Skeletal muscle metabolic dysfunction in obesity and metabolic syndrome.

Authors:  Greg D Wells; Michael D Noseworthy; Jill Hamilton; Mark Tarnopolski; Ingrid Tein
Journal:  Can J Neurol Sci       Date:  2008-03       Impact factor: 2.104

5.  Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice.

Authors:  Jiandie Lin; Pei-Hsuan Wu; Paul T Tarr; Katrin S Lindenberg; Julie St-Pierre; Chen-Yu Zhang; Vamsi K Mootha; Sibylle Jäger; Claudia R Vianna; Richard M Reznick; Libin Cui; Monia Manieri; Mi X Donovan; Zhidan Wu; Marcus P Cooper; Melina C Fan; Lindsay M Rohas; Ann Marie Zavacki; Saverio Cinti; Gerald I Shulman; Bradford B Lowell; Dimitri Krainc; Bruce M Spiegelman
Journal:  Cell       Date:  2004-10-01       Impact factor: 41.582

Review 6.  Dual-specificity MAP kinase phosphatases (MKPs) and cancer.

Authors:  Stephen M Keyse
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

7.  High-fat diets cause insulin resistance despite an increase in muscle mitochondria.

Authors:  Chad R Hancock; Dong-Ho Han; May Chen; Shin Terada; Toshihiro Yasuda; David C Wright; John O Holloszy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-28       Impact factor: 11.205

8.  Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice.

Authors:  Charlotte Bonnard; Annie Durand; Simone Peyrol; Emilie Chanseaume; Marie-Agnes Chauvin; Béatrice Morio; Hubert Vidal; Jennifer Rieusset
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.

Authors:  Mary Elizabeth Patti; Atul J Butte; Sarah Crunkhorn; Kenneth Cusi; Rachele Berria; Sangeeta Kashyap; Yoshinori Miyazaki; Isaac Kohane; Maura Costello; Robert Saccone; Edwin J Landaker; Allison B Goldfine; Edward Mun; Ralph DeFronzo; Jean Finlayson; C Ronald Kahn; Lawrence J Mandarino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 12.779

Review 10.  Skeletal muscle fiber type: influence on contractile and metabolic properties.

Authors:  Juleen R Zierath; John A Hawley
Journal:  PLoS Biol       Date:  2004-10-12       Impact factor: 8.029

View more
  31 in total

1.  Skeletal Muscle-Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance.

Authors:  Ahmed Lawan; Kisuk Min; Lei Zhang; Alberto Canfran-Duque; Michael J Jurczak; Joao Paulo G Camporez; Yaohui Nie; Timothy P Gavin; Gerald I Shulman; Carlos Fernandez-Hernando; Anton M Bennett
Journal:  Diabetes       Date:  2018-01-09       Impact factor: 9.461

Review 2.  Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease.

Authors:  Louise M Collins; Eric J Downer; André Toulouse; Yvonne M Nolan
Journal:  Mol Neurobiol       Date:  2014-06-24       Impact factor: 5.590

3.  Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway.

Authors:  Jennifer Murray; Janice M Huss
Journal:  Am J Physiol Cell Physiol       Date:  2011-05-11       Impact factor: 4.249

Review 4.  Mitogen-activated protein kinase phosphatase-1 - a potential therapeutic target in metabolic disease.

Authors:  Rachel J Roth Flach; Anton M Bennett
Journal:  Expert Opin Ther Targets       Date:  2010-12       Impact factor: 6.902

Review 5.  Orexin: pathways to obesity resistance?

Authors:  Tammy A Butterick; Charles J Billington; Catherine M Kotz; Joshua P Nixon
Journal:  Rev Endocr Metab Disord       Date:  2013-12       Impact factor: 6.514

6.  MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy.

Authors:  Hao Shi; Emmanuel Boadu; Fatih Mercan; Annie M Le; Rachel J Roth Flach; Lei Zhang; Kristina J Tyner; Bradley B Olwin; Anton M Bennett
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

7.  Improved regenerative myogenesis and muscular dystrophy in mice lacking Mkp5.

Authors:  Hao Shi; Mayank Verma; Lei Zhang; Chen Dong; Richard A Flavell; Anton M Bennett
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

Review 8.  MAP kinase phosphatase-1--a new player at the nexus between sarcopenia and metabolic disease.

Authors:  Rachel J Roth Flach; Anton M Bennett
Journal:  Aging (Albany NY)       Date:  2010-04-06       Impact factor: 5.682

9.  O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability.

Authors:  Hai-Bin Ruan; Xuemei Han; Min-Dian Li; Jay Prakash Singh; Kevin Qian; Sascha Azarhoush; Lin Zhao; Anton M Bennett; Varman T Samuel; Jing Wu; John R Yates; Xiaoyong Yang
Journal:  Cell Metab       Date:  2012-08-08       Impact factor: 27.287

10.  Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Khortnal Delvecchio; Han-Zhong Feng; Gregory D Cartee; Jian-Ping Jin; Assia Shisheva
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.